P. Worst

1.6k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

P. Worst is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, P. Worst has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in P. Worst's work include Lymphoma Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Skin and Cellular Biology Research (2 papers). P. Worst is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Skin and Cellular Biology Research (2 papers). P. Worst collaborates with scholars based in Germany, Sweden and United Kingdom. P. Worst's co-authors include Norbert E. Fusenig, George Klein, Henry Harris, T Tachibana, N. E. Fusenig, Ian C. Mackenzie, Elizabeth Valentine, Petra Boukamp, Volker Diehl and Andreas Engert and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

P. Worst

20 papers receiving 989 citations

Hit Papers

Suppression of Malignancy by Cell Fusion 1969 2026 1988 2007 1969 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Worst Germany 13 401 358 265 190 141 20 1.1k
Koichi Rikimaru Japan 13 544 1.4× 517 1.4× 67 0.3× 110 0.6× 121 0.9× 20 1.0k
Kay H. Singer United States 19 218 0.5× 161 0.4× 157 0.6× 115 0.6× 42 0.3× 28 1.2k
Hiromaro Kiryu Japan 15 332 0.8× 460 1.3× 146 0.6× 63 0.3× 187 1.3× 59 1.4k
Carol J. Schlueter United States 6 324 0.8× 305 0.9× 118 0.4× 46 0.2× 158 1.1× 7 1.1k
Pierce Gb United States 14 490 1.2× 242 0.7× 44 0.2× 171 0.9× 107 0.8× 22 1.1k
Julian Mackay‐Wiggan United States 14 641 1.6× 202 0.6× 475 1.8× 257 1.4× 72 0.5× 26 2.0k
Sven Krengel Germany 18 269 0.7× 681 1.9× 115 0.4× 212 1.1× 68 0.5× 43 1.1k
Caroline Hutter Austria 15 363 0.9× 211 0.6× 112 0.4× 178 0.9× 67 0.5× 32 1.2k
Christiane Querfeld United States 31 549 1.4× 954 2.7× 1.5k 5.5× 81 0.4× 119 0.8× 155 3.4k
Sandrine Lenglez Belgium 10 694 1.7× 379 1.1× 88 0.3× 158 0.8× 64 0.5× 13 1.2k

Countries citing papers authored by P. Worst

Since Specialization
Citations

This map shows the geographic impact of P. Worst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Worst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Worst more than expected).

Fields of papers citing papers by P. Worst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Worst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Worst. The network helps show where P. Worst may publish in the future.

Co-authorship network of co-authors of P. Worst

This figure shows the co-authorship network connecting the top 25 collaborators of P. Worst. A scholar is included among the top collaborators of P. Worst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Worst. P. Worst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ballová, Veronika, Jens Ulrich Rüffer, Heinz Haverkamp, et al.. (2004). A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly). Annals of Oncology. 16(1). 124–131. 109 indexed citations
5.
Possinger, K., Helmut Wagner, P. Worst, et al.. (1991). Oral Administration of Idarubicin as First Line Cytostatic Therapy in Patients with Metastasized Breast Cancer and Favourable Prognosis. Oncology Research and Treatment. 14(1). 31–34. 11 indexed citations
6.
Worst, P., et al.. (1990). Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer. Cancer Chemotherapy and Pharmacology. 26(S1). S87–S90. 14 indexed citations
7.
Heim, Manfred, et al.. (1989). Sequential High Dose Methotrexate, 5-Fluorouracil and Folinic Acid Does Not Improve Response Rates in Advanced Colorectal Cancer. Oncology Research and Treatment. 12(4). 161–163. 3 indexed citations
8.
Paschke, Reinhard, et al.. (1988). Hepatotoxizität bei Etoposid-Ifosfamid-Kombinations-Chemotherapie. Oncology Research and Treatment. 11(6). 273–275. 7 indexed citations
9.
Hoffmann, G. M., P. Worst, & Manfred Heim. (1986). Ifosfamide and etoposide as second line therapy in advanced breast cancer. Journal of Cancer Research and Clinical Oncology. 111(S1). S33–S33. 1 indexed citations
10.
Worst, P., Ian C. Mackenzie, & N. E. Fusenig. (1982). Reformation of organized epidermal structure by transplantation of suspensions and cultures of epidermal and dermal cells. Cell and Tissue Research. 225(1). 65–77. 68 indexed citations
11.
Fusenig, Norbert E., et al.. (1978). Characteristics of chemically transformed mouse epidermal cells in vitro and in vivo.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 65(3). 271–9. 63 indexed citations
12.
Fusenig, Norbert E. & P. Worst. (1975). Mouse epidermal cell cultures. Experimental Cell Research. 93(2). 443–457. 85 indexed citations
13.
Worst, P., et al.. (1975). Skin transplantation in the study of chemical carcinogenesis. Journal of Cancer Research and Clinical Oncology. 84(2). 97–103. 1 indexed citations
14.
Worst, P., et al.. (1974). Skin transplantation in the study of chemical carcinogenesis. Journal of Cancer Research and Clinical Oncology. 82(4). 285–94. 3 indexed citations
15.
Fusenig, Norbert E. & P. Worst. (1974). Mouse Epidermal Cell Cultures I. Isolation and Cultivation of Epidermal Cells from Adult Mouse Skin. Journal of Investigative Dermatology. 63(2). 187–193. 31 indexed citations
16.
Worst, P., Elizabeth Valentine, & Norbert E. Fusenig. (1974). Formation of Epidermis After Reimplantation of Pure Primary Epidermal Cell Cultures From Perinatal Mouse Skin 2. JNCI Journal of the National Cancer Institute. 53(4). 1061–1064. 51 indexed citations
17.
Worst, P. & Norbert E. Fusenig. (1973). A Tissue Antigen on the Surface of Cultivated Mouse Epidermal Cells Detected by Mixed Hemadsorption Technique. Journal of Investigative Dermatology. 61(5). 277–281. 14 indexed citations
18.
Worst, P. & Norbert E. Fusenig. (1973). HISTOCOMPATIBILITY ANTIGENS ON THE SURFACE OF CULTIVATED EPIDERMAL CELLS FROM MOUSE EMBRYO SKIN. Transplantation. 15(4). 375–382. 10 indexed citations
19.
Tachibana, Takehiko, P. Worst, & Eva Klein. (1970). Detection of cell surface antigens on monolayer cells. II. The application of mixed haemadsorption on a micro scale.. PubMed. 19(5). 809–16. 15 indexed citations
20.
Harris, Henry, et al.. (1969). Suppression of Malignancy by Cell Fusion. Nature. 223(5204). 363–368. 440 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026